CAS 2416417-65-5

Formel: C15H17F3N2O

InChl: InChI=1S/C15H17F3N2O/c1-3-13(21)20-8-7-14(2,10-20)19-12-6-4-5-11(9-12)15(16,17)18/h3-6,9,19H,1,7-8,10H2,2H3

InChI Key: MTBDEVWWJBIUOK-UHFFFAOYSA-N

SMILES: CC1(CCN(C1)C(=O)C=C)NC2=CC=CC(=C2)C(F)(F)F

MYF-01-37

CAS: 2416417-65-5

MYF-01-37

Formel: C₁₅H₁₇F₃N₂O

Reinheit: 99.5%

Molekulargewicht: 298.3

Ref: 54-BUP12974

MYF-01-37

CAS: 2416417-65-5

Formel: C₁₅H₁₇F₃N₂O

Reinheit: 98%

Molekulargewicht: 298.3035

Ref: IN-DA01X7DG

MYF-01-37

CAS: 2416417-65-5

1-(3-Methyl-3-((3-(trifluoromethyl)phenyl)amino)pyrrolidin-1-yl)prop-2-en-1-one

Formel: C₁₅H₁₇F₃N₂O

Reinheit: 99%

Molekulargewicht: 298.3

Ref: IN-DG01326038

MYF-01-37

CAS: 2416417-65-5

MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) is a novel covalent TEAD inhibitor.

Formel: C₁₅H₁₇F₃N₂O

Reinheit: 99.46% - 99.5%

Farbe und Form: Solid

Molekulargewicht: 298.3035

Ref: TM-T22372

MYF-01-37

CAS: 2416417-65-5

MYF-01-37 is a peptide that inhibits the activation of the L-type voltage-gated calcium channel. It has been shown to inhibit the proliferation of human breast cancer cells with high purity, and has been used as a research tool for studying ion channels and cell biology. MYF-01-37 was developed by Dr. Yang at the University of California, Irvine, and is CAS No. 2416417-65-5.

Formel: C₁₅H₁₇F₃N₂O

Reinheit: Min. 95%

Molekulargewicht: 298.3 g/mol

Ref: 3D-RWD41765